{"entity":{"type":"insider","cik":"0001435745","url":"/insider/0001435745","json_url":"/insider/0001435745.json","name":"Bamforth Mark R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":7,"first":"2008-08-07","last":"2021-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Bamforth Mark R","source":"filing","n_filings":7,"first_seen":"2008-08-07","last_seen":"2021-03-19"}],"transactions":[{"id":5420418,"accession":"0001683168-21-001011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001683168-21-001011","line_url":"/filing/0001683168-21-001011","is_derivative":false,"issuer_cik":"0000704562","issuer_name":"Avid Bioservices, Inc.","issuer_ticker":"CDMO","issuer_name_source":null,"issuer_url":"/issuer/0000704562","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126000.0,"shares_display":"126,000","price_per_share":18.18,"price_display":"18.18","price_state":"stated","total_value":2290680.0,"total_display":"2,290,680.00","total_whole":"2,290,680","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-19","scope":"insider","n_lines":2},{"id":5420413,"accession":"0001683168-21-001011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-21-001011","line_url":"/filing/0001683168-21-001011#line-1","is_derivative":false,"issuer_cik":"0000704562","issuer_name":"Avid Bioservices, Inc.","issuer_ticker":"CDMO","issuer_name_source":null,"issuer_url":"/issuer/0000704562","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":126000.0,"shares_display":"126,000","price_per_share":18.18,"price_display":"18.18","price_state":"stated","total_value":2290680.0,"total_display":"2,290,680.00","total_whole":"2,290,680","shares_owned_after":126000.0,"shares_owned_after_display":"126,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-17","filed_date":"2021-03-19","scope":"insider"},{"id":2875972,"accession":"0001683168-20-000827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-20-000827","line_url":"/filing/0001683168-20-000827#line-1","is_derivative":false,"issuer_cik":"0000704562","issuer_name":"Avid Bioservices, Inc.","issuer_ticker":"CDMO","issuer_name_source":null,"issuer_url":"/issuer/0000704562","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":104260.0,"total_display":"104,260.00","total_whole":"104,260","shares_owned_after":26000.0,"shares_owned_after_display":"26,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-16","scope":"insider"},{"id":6800611,"accession":"0001683168-18-000476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001683168-18-000476","line_url":"/filing/0001683168-18-000476#line-1","is_derivative":false,"issuer_cik":"0000704562","issuer_name":"Avid Bioservices, Inc.","issuer_ticker":"CDMO","issuer_name_source":null,"issuer_url":"/issuer/0000704562","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-20","scope":"insider"},{"id":4600273,"accession":"0001683168-17-002766","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001683168-17-002766","line_url":"/filing/0001683168-17-002766","is_derivative":false,"issuer_cik":"0000704562","issuer_name":"PEREGRINE PHARMACEUTICALS INC","issuer_ticker":"PPHM","issuer_name_source":null,"issuer_url":"/issuer/0000704562","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.5018221,"price_display":"4.50","price_state":"stated","total_value":225091.105,"total_display":"225,091.10","total_whole":"225,091","shares_owned_after":48800.0,"shares_owned_after_display":"48,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-27","filed_date":"2017-10-27","scope":"insider","n_lines":8},{"id":5810333,"accession":"0000732485-09-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000732485-09-000009","line_url":"/filing/0000732485-09-000009#line-1","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Officer (Sr.VP, Corp. Operations & Phar)","role_mark":"O","role_mark_label":"Officer (Sr.VP, Corp. Operations & Phar)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP, Corp. Operations & Phar","security_title":"Genzyme common stock (GENZ)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":54.54,"price_display":"54.54","price_state":"stated","total_value":38178.0,"total_display":"38,178.00","total_whole":"38,178","shares_owned_after":3775.0,"shares_owned_after_display":"3,775","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-03-04","filed_date":"2009-03-06","scope":"insider"},{"id":3918057,"accession":"0000732485-08-000027","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000732485-08-000027","line_url":"/filing/0000732485-08-000027#line-3","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Officer (Sr.VP, Corp. Operations & Phar)","role_mark":"O","role_mark_label":"Officer (Sr.VP, Corp. Operations & Phar)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP, Corp. Operations & Phar","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19232.0,"shares_display":"19,232","price_per_share":81.71,"price_display":"81.71","price_state":"stated","total_value":1571446.72,"total_display":"1,571,446.72","total_whole":"1,571,447","shares_owned_after":158.0,"shares_owned_after_display":"158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-14","filed_date":"2008-08-15","scope":"insider"},{"id":3868614,"accession":"0000732485-08-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000732485-08-000024","line_url":"/filing/0000732485-08-000024#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001435745","owner_name":"Bamforth Mark R","owner_display_name":"Bamforth Mark R","owner_url":"/insider/0001435745","role":"Officer (Sr.VP, Corp. Operations & Phar)","role_mark":"O","role_mark_label":"Officer (Sr.VP, Corp. Operations & Phar)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP, Corp. Operations & Phar","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6445.0,"shares_display":"6,445","price_per_share":79.0,"price_display":"79.00","price_state":"stated","total_value":509155.0,"total_display":"509,155.00","total_whole":"509,155","shares_owned_after":158.0,"shares_owned_after_display":"158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-06","filed_date":"2008-08-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000704562","name":"Avid Bioservices, Inc.","url":"/issuer/0000704562","role":"Director","n_filings":4,"first_seen":"2017-10-27","last_seen":"2021-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000732485","name":"GENZYME CORP","url":"/issuer/0000732485","role":"Officer (Sr.VP, Corp. Operations & Phar)","n_filings":3,"first_seen":"2008-08-07","last_seen":"2009-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001435745","retrieved_at":"2026-08-22T16:28:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}